Jack Cowland

Dr. Jack Cowland


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

25 August 2016 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
JCJack Cowland
Jack Cowland
NBNiels Borregaard
Niels Borregaard

1 October 2000 in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
Verified
Journal Article
Closed access
LKLars Kjeldsen
Lars Kjeldsen
JCJack Cowland
Jack Cowland
NBNiels Borregaard
Niels Borregaard

24 December 2004 in FEBS Letters
Verified
Journal Article
Closed access
VHVibeke Hvidberg
Vibeke Hvidberg
CJChristian Jacobsen
Christian Jacobsen
RSRoland K. Strong
Roland K. Strong
JCJack Cowland
Jack Cowland
SMSoren Kragh Moestrup
Soren Kragh Moestrup
NBNiels Borregaard
Niels Borregaard

15 December 2003 in The Journal of Immunology
Verified
Journal Article
Closed access
JCJack Cowland
Jack Cowland
OSOle E Sørensen
Ole E Sørensen
MSMaxwell Sehested
Maxwell Sehested
NBNiels Borregaard
Niels Borregaard
Synthesis of the antimicrobial protein neutrophil gelatinase-associated lipocalin (NGAL) increases dramatically in bronchial epithelial cells and alveolear type II pneumocytes during lung inflammation. IL-1β induces a >10-fold up-regulation of NGAL expression in the type II pneumocyte-derived cell line A549 cells, whereas TNF-α, IL-6, and LPS had no effect. Similar IL-1β selectivity was demonstrated in primary bronchial epithelial cells and epidermal keratinocytes and for an NGAL promoter fragment transfected into A549 cells. By deletion and substitution analysis of the NGAL promoter, a 40-bp region containing an NF-κB consensus site was found to control the IL-1β-specific up-regulation. Involvement of the NF-κB site was demonstrated by site-directed mutagenesis, by transfection with a dominant-negative inhibitor of the NF-κB pathway, and by EMSA. TNF-α activation of NF-κB, in contrast, did not increase NGAL synthesis, even though induced binding of NF-κB to the NGAL promoter was observed in vitro. IL-1β specificity was not contained within the NF-κB site of the NGAL promoter, as determined by exchanging the NGAL promoter′s NF-κB-binding sequence with that of the IL-8 promoter or with the NF-κB consensus sequence and by testing the NF-κB-binding sequence of the NGAL promoter against the heterologous SV40 promoter. Selectivity for the IL-1 pathway was substantiated by demonstrating that NGAL promoter activity could be induced by LPS stimulation of A549 cells transiently expressing Toll-like receptor 4, which use the same intracellular signaling pathway as the IL-1R. Together, this demonstrates a selective up-regulation of NGAL by the IL-1 pathway.

1 June 2003 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
OSOle E Sørensen
Ole E Sørensen
JCJack Cowland
Jack Cowland
KTKim Theilgaard-MönCh
Kim Theilgaard-MönCh
LLLide Liu
Lide Liu
TGTomas Ganz
Tomas Ganz
NBNiels Borregaard
Niels Borregaard
In addition to acting as a physical barrier against microorganisms, the skin produces antimicrobial peptides and proteins. After wounding, growth factors are produced to stimulate the regeneration of tissue. The growth factor response ceases after regeneration of the tissue, when the physical barrier protecting against microbial infections is re-established. We found that the growth factors important in wound healing, insulin-like growth factor I and TGF-α, induce the expression of the antimicrobial peptides/polypeptides human cationic antimicrobial protein hCAP-18/LL-37, human β-defensin 3, neutrophil gelatinase-associated lipocalin, and secretory leukocyte protease inhibitor in human keratinocytes. Both an individual and a synergistic effect of these growth factors were observed. These findings offer an explanation for the expression of these peptides/polypeptides in the skin disease psoriasis and in wound healing and define a host defense role for growth factors in wound healing.